Cadence Capital Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-981
Closed -$229K 421
2019
Q2
$229K Buy
981
+31
+3% +$7.16K 0.02% 395
2019
Q1
$225K Buy
950
+1
+0.1% +$315 0.02% 428
2018
Q4
$286K Sell
949
-5,150
-84% -$1.64M 0.03% 397
2018
Q3
$2.15M Sell
6,099
-614
-9% -$211K 0.12% 243
2018
Q2
$1.95M Buy
6,713
+81
+1% +$22.8K 0.12% 241
2018
Q1
$1.82M Buy
6,632
+161
+2% +$50K 0.12% 219
2017
Q4
$2.06M Buy
6,471
+54
+0.8% +$17.3K 0.13% 182
2017
Q3
$2.01M Sell
6,417
-4,141
-39% -$1.23M 0.13% 189
2017
Q2
$2.87M Sell
10,558
-1,178
-10% -$311K 0.2% 123
2017
Q1
$3.21M Buy
11,736
+883
+8% +$250K 0.22% 111
2016
Q4
$3.08M Buy
10,853
+361
+3% +$107K 0.22% 111
2016
Q3
$3.28M Buy
10,492
+1,227
+13% +$363K 0.24% 108
2016
Q2
$2.24M Sell
9,265
-75
-0.8% -$19.8K 0.17% 149
2016
Q1
$2.43M Buy
9,340
+19
+0.2% +$5.02K 0.17% 142
2015
Q4
$2.85M Sell
9,321
-440
-5% -$126K 0.19% 140
2015
Q3
$2.85M Buy
9,761
+2,547
+35% +$841K 0.2% 128
2015
Q2
$2.91M Sell
7,214
-77
-1% -$30.9K 0.16% 159
2015
Q1
$3.08M Sell
7,291
-329
-4% -$130K 0.19% 147
2014
Q4
$2.59M Buy
+7,620
New +$2.47M 0.15% 185

Other funds holding BIIB